Answers are grounded in this paper and cite their sources.
Comparative analysis finds potential impulse control disorder risks associated with GPi-DBS in Parkinson's patients, suggesting caution in treatment decisions.
GPi-DBS may increase the risk for de novo ICDs. This observation should be interpreted with caution because of the small sample size and low statistical significance. Additional research may clarify the relationships between DBS targets and ICD outcomes.
No takes yet. Share an insight, caveat, or question.
Combs et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: